Answers are grounded in this paper and cite their sources.
Combining ADs seems to be superior to monotherapy with only slightly more patients dropping out. Combining a reuptake inhibitor with an antagonist of presynaptic α2-autoreceptors seems to be significantly more effective than other combinations. Overall, our search revealed a dearth of well-designed studies.
No takes yet. Share an insight, caveat, or question.
Henssler et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: